Medicare Enrolled

Dr. Steven Geller, DO

Pulmonary Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3998 RED LION ROAD, Philadelphia, PA 19114
2156128500
In practice since 2006 (19 years)
NPI: 1194836387 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Geller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Geller? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Geller

Dr. Steven Geller is a pulmonary disease specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Geller performed 1,172 Medicare services across 762 unique beneficiaries.

Between the years covered by Open Payments, Dr. Geller received a total of $242,468 from 53 pharmaceutical and/or device companies across 1255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Geller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 22% volume in PA $242,468 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,172
Medicare services
Top 22% in PA for pulmonary disease
762
Unique beneficiaries
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
485 $95 $275
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
326 $63 $130
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
93 $63 $190
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
64 $117 $350
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
61 $98 $190
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
52 $105 $245
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
24 $142 $360
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
19 $33 $120
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
17 $13 $125
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
16 $24 $120
Initial hospital admission, low complexity
Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter.
15 $63 $175
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$242,468
Total received (2018-2024)
Avg $34,638/year across 7 years
Top 2% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
1,255
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$226,426 (93.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,042 (6.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$63,464
2023
$68,326
2022
$45,075
2021
$35,190
2020
$16,675
2019
$3,787
2018
$9,950

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$36,342
GlaxoSmithKline, LLC.
$24,400
Regeneron Healthcare Solutions, Inc.
$466
JAZZ PHARMACEUTICALS INC.
$360
GENZYME CORPORATION
$291
Boehringer Ingelheim Pharmaceuticals, Inc.
$285
HARMONY BIOSCIENCES LLC
$203
Electromed, Inc.
$172
Actelion Pharmaceuticals US, Inc.
$162
Amgen Inc.
$123
Inspire Medical Systems, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$71
Philips North America LLC
$69
Mallinckrodt Hospital Products Inc.
$63
ANI Pharmaceuticals, Inc.
$58
Axsome Therapeutics, Inc.
$57
Insmed, Inc.
$47
Genentech USA, Inc.
$43
Baxter Healthcare
$35
United Therapeutics Corporation
$20
Optinose US, Inc.
$20
Mylan Specialty L.P.
$20
Myriad Genetic Laboratories, Inc.
$18
Pulmonx Corporation
$17
PFIZER INC.
$17
La Jolla Pharmaceutical Company
$16
WATERMARK MEDICAL, INC.
$14
Top 3 companies account for 96.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$136,800
AstraZeneca Pharmaceuticals LP
$87,017
Amgen Inc.
$4,279
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,644
Regeneron Healthcare Solutions, Inc.
$1,613
United Therapeutics Corporation
$1,347
Mylan Specialty L.P.
$1,141
Actelion Pharmaceuticals US, Inc.
$1,036
GENZYME CORPORATION
$984
JAZZ PHARMACEUTICALS INC.
$615
Insmed, Inc.
$586
Takeda Pharmaceuticals U.S.A., Inc.
$537
Philips Electronics North America Corporation
$529
Genentech USA, Inc.
$453
HARMONY BIOSCIENCES LLC
$415
Electromed, Inc.
$393
Grifols USA, LLC
$384
Advanced Respiratory, Inc
$306
Baxter Healthcare
$253
Mallinckrodt Hospital Products Inc.
$211
Shire North American Group Inc
$182
Sunovion Pharmaceuticals Inc.
$169
Merck Sharp & Dohme Corporation
$156
Mallinckrodt Enterprises LLC
$119
Teva Pharmaceuticals USA, Inc.
$111
ANI Pharmaceuticals, Inc.
$103
Inspire Medical Systems, Inc.
$101
Janssen Pharmaceuticals, Inc
$101
Novartis Pharmaceuticals Corporation
$95
Axsome Therapeutics, Inc.
$91
Harmony Biosciences LLC
$87
Philips North America LLC
$69
Jazz Pharmaceuticals Inc.
$69
Mallinckrodt LLC
$58
Merck Sharp & Dohme LLC
$50
ADVANCED RESPIRATORY, INC
$43
PFIZER INC.
$30
Bayer Healthcare Pharmaceuticals Inc.
$29
Resmed Corp
$28
Cumberland Pharmaceuticals, Inc.
$23
Sumitomo Pharma America, Inc.
$20
Optinose US, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$19
Myriad Genetic Laboratories, Inc.
$18
Pulmonx Corporation
$17
La Jolla Pharmaceutical Company
$16
SANOFI-AVENTIS U.S. LLC
$16
Circassia Pharmaceuticals Inc
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$15
CSL Behring
$14
WATERMARK MEDICAL, INC.
$14
Shionogi Inc
$13
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
(2928) NIV other · (8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADVAIR · AIRSENSE · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · ARALAST · ARES 620 UNICORDER · AREXVY · ASMANEX · Adempas · AirDuo Digihaler · Arikayce · Astral · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHARTIS CATHETER · CINQAIR · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · Esbriet · FASENRA · Fetroja · GEMTESA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · IMFINZI · INSPIRE · KEYTRUDA · Kcentra · LONHALA MAGNAIR · LifeVest · Lunoa 1 0 · NONE · NUCALA · Nubeqa · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PROLARIS · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · REMODULIN · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vibativ · Volara System · WAKIX · Wakix · Wellcentive Undiv · XACDURO · XARELTO · XOLAIR · XYREM · XYWAV · Xhance · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in PA.

Looking for a pulmonary disease specialist in Philadelphia?
Compare pulmonary diseases in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
271
Per 100K population
17.1
County median income
$60,698
Nearest hospital
JEFFERSON HEALTH- NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Geller is a clinical cardiology specialist, with above-average Medicare volume (top 22% in PA), with speaking/promotional industry engagement in the top 2% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Geller experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Geller performed 485 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Geller receive payments from pharmaceutical companies?
Yes. Dr. Geller received a total of $242,468 from 53 companies across 1,255 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Geller's costs compare to other pulmonary diseases in Philadelphia?
Dr. Geller's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Geller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →